Bharat Biotech on Thursday released a statement highlighting the safety measures taken during the development of its COVID-19 vaccine amid debate over the side effects of Covishield. The assertion ...
NEW DELHI: Bharat Biotech on Thursday assured Covaxin's safety amid debate over Astrazeneca's admission that its Covid-19 vaccine, sold as Covishield in India, could cause "rare' side effects.
Amid a row over AstraZeneca's admission of potential side effects of its Covid-19 vaccine, Bharat Biotech said that its Covaxin vaccine was developed with a single-minded focus on safety first, ...
Amid widespread concern over Thrombosis with Thrombocytopenia Syndrome - a rare side-effect of the Covishield COVID-19 vaccine - the Serum Institute - which made the drug developed by British ...
Bharat Biotech on Thursday said that it developed Covaxin with a single-minded focus on safety first, followed by efficacy. In a statement on the ongoing debate on the the side effects of ...
Amid the debate over Astra Zeneca's alleged side-effects, Bharat Biotech has said that Covaxin was developed with a single-minded focus on safety first, followed by efficacy. The Covid vaccine maker ...
Several studies on Covaxin have demonstrated an excellent safety track record, said Bharat Biotech on Thursday, after a study ...
Amid reports of adverse events from Covaxin and Covishield COVID-19 vaccines, questions about the vaccine's safety have been ...
Hyderabad: Days after AstraZeneca’s admision in a UK court on its Covid-19 vaccine causing a rare side-effect — Thrombosis with Thrombocytopenia Syndrome (TTS), Indian vaccine maker Bharat ...
(MENAFN- Live Mint) "Bharat Biotech released a statement highlighting the safety and efficacy measures taken during the development of its COVID-19 vaccine on Thursday amid debate over the side ...
Bharat Biotech on Thursday said that it developed Covaxin with a single-minded focus on safety first, followed by efficacy. In a statement on the ongoing debate on the the side effects of ...